APP and early-onset autosomal dominant Alzheimer disease: Rd, a Chinese herb, may be a promising treatment drug for Alzheimer′s disease (AD) and is also reported to be related to several pathological changes, including the deposition of Aβ and tau hyperphosphorylation in AD as it decreases the deposition of tau hyperphosphorylation in APP transgenic mice.